Trusted Resource for Clinical Trials, Protocols & Progress
Randomized Controlled Phase 2 Trials: Pros and Cons Evaluating the Pros and Cons of Randomized Controlled Trials in Phase 2 Introduction Randomized controlled trials (RCTs) are often considered the gold standard in clinical research due to their ability to minimize bias and provide high-quality evidence. In Phase 2 clinical trials, where the goal is to…
Read More “Randomized Controlled Phase 2 Trials: Pros and Cons” »
Comparative Effectiveness Research in Phase 4 Clinical Trials: Real-World Value Assessment How Phase 4 Trials Enable Comparative Effectiveness Research in Real-World Settings What Is Comparative Effectiveness Research (CER)? Comparative Effectiveness Research (CER) refers to the direct comparison of different treatment options to evaluate which works best for specific populations or under real-world conditions. In Phase…
Statistical Considerations and Sample Size Justification in Phase 3 Clinical Trials How to Plan Statistical Parameters and Sample Size in Phase 3 Trials Why Statistical Planning is Crucial in Phase 3 Trials Statistical considerations are the backbone of any well-designed Phase 3 clinical trial. These trials are the final stage before regulatory approval, so every…
Read More “Statistical Considerations and Sample Size Justification in Phase 3 Clinical Trials” »
Selecting the Right Candidates for Phase 0: Drug Selection Criteria How to Choose the Right Drug Candidates for Phase 0 Clinical Trials Why Drug Selection Matters in Phase 0 Trials Not every drug candidate is suitable for a Phase 0 microdosing study. These trials are designed to generate early pharmacokinetic (PK) and pharmacodynamic (PD) data…
Read More “Selecting the Right Candidates for Phase 0: Drug Selection Criteria” »
Determining the Starting Dose for First-in-Human Trials (MABEL, NOAEL, BSA) Determining the Starting Dose for First-in-Human Trials: MABEL, NOAEL, and BSA Explained Introduction In first-in-human (FIH) trials, selecting the initial dose is one of the most important and scrutinized decisions. Too high, and you risk harm to participants. Too low, and the data may be…
Read More “Determining the Starting Dose for First-in-Human Trials (MABEL, NOAEL, BSA)” »
Common Study Designs in Phase 2 Trials Exploring Common Study Designs Used in Phase 2 Clinical Trials Introduction Phase 2 clinical trials are designed to evaluate whether a new therapeutic candidate is effective in a specific patient population. Since these trials follow the safety-focused Phase 1 stage, the emphasis shifts toward efficacy assessment, dose optimization,…
Observational vs Interventional Studies in Phase 4 Clinical Trials: Key Differences and Design Strategies How to Choose Between Observational and Interventional Designs in Phase 4 Trials Overview of Study Designs in Phase 4 Once a drug is approved and enters the market, Phase 4 studies begin to monitor its performance in the real world. These…
The Role of Randomized Controlled Trials in Phase 3 Clinical Trials – Methodology, Importance, and Application How Randomized Controlled Trials Shape the Success of Phase 3 Clinical Research Introduction: Why Randomization is Essential in Clinical Trials Randomized Controlled Trials (RCTs) are considered the gold standard in clinical research. In Phase 3 clinical trials, where the…
How to Design a Microdosing Study in Phase 0 Trials A Step-by-Step Guide to Designing a Microdosing Study for Phase 0 Trials What is a Microdosing Study? A microdosing study involves the administration of extremely low, sub-therapeutic doses of a drug to human subjects to evaluate early pharmacokinetic (PK) and pharmacodynamic (PD) behavior. These studies…
Read More “How to Design a Microdosing Study in Phase 0 Trials” »
Site Selection and Infrastructure Needs for Early-Phase Trials Site Selection and Infrastructure Needs for Early-Phase Trials Introduction Early-phase clinical trials—especially Phase 1 studies—require specialized environments for participant safety, data integrity, and regulatory compliance. Choosing the right site is a critical success factor. From facility readiness to investigator experience, this tutorial explores how to select, prepare,…
Read More “Site Selection and Infrastructure Needs for Early-Phase Trials” »
